| Literature DB >> 35366827 |
Baodi Yang1, Hailan Liao2, Minghua Wang2, Qiaoyan Long2, Huanhuan Zhong2, Lin Luo2, Zhongmin Liu2, Xiaohui Cheng2.
Abstract
BACKGROUND: Kimura's disease is a rare, benign, chronic inflammatory disease that presents as painless, solid masses mainly affecting the deep subcutaneous areas of the head and neck, especially the salivary glands, parotid glands and nearby lymph nodes. It is characterized by elevated peripheral blood eosinophil and Immunoglobulin E (IgE) levels. CASEEntities:
Keywords: Eosinophils; Fossa Cubitalis; Groin; Immunoglobulin E; Kimura’s disease; Orbit
Mesh:
Year: 2022 PMID: 35366827 PMCID: PMC8977031 DOI: 10.1186/s12886-022-02378-y
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Fig. 1Orbital CT. A shows the lesion mass is medium density. The deep part is adhered to the optic nerve (sagittal scan); B shows part lesion invades the infraorbital fissure (coronal scan); C shows the lesion is adjacent to the medial rectus muscle and is inhomogeneous contrast enhancement (horizontal enhanced scan); D reveals the subcutaneous thickening (horizontal enhanced scan)
Fig. 2Orbital MRI. T1 weighted image shows the lesion is low signal (A, orbital horizontal scan); T2 weighted image shows medium signal (B, orbital sagittal scan); The lesion mass is significantly enhanced (C, orbital sagittal enhanced scan); Part lesion is adhesion to the inferior rectus muscle and optic nerve (B and C)
Fig. 3The lower abdomen CT. A and B reveal multiple nodular masses in the groin on both sides; C and D reveal inhomogeneous contrast enhancement in the arterial phase
Fig. 4The left orbital colour Doppler ultrasound. The orbital subnasal lesion mass is in the size of 2.16*1.37 cm, and has a heterogeneous hypoechoic-isoechoic appearance; the blood flow is relatively rich
Fig. 5The Colour Doppler ultrasound of bilateral elbow. The bilateral elbow masses are oval in shape and have a heterogeneous hypoechoic-isoechoic appearance; the blood flows are relatively rich. (A is the right elbow; B is the left elbow)
Fig. 6Ocular Appearance. (A) shows the left eyeball protopsis at the time of intravenous drip of methylprednisolone (40 mg) for one day; (B) shows the left eyeball protopsis is significantly alleviative at the time of intravenous drip of methylprednisolone (40 mg) for five days
Fig. 7Surgical removal of the left elbow mass. The mass was further for pathological examination
Fig. 8The pathological characteristics of elbow mass. A The gross view of pathological sections. In the cortical region, hyperplasia of numerous lymphoid follicles with active germinal centers (× 20); B Magnification of the marked region with the rectangle in (A). Strong eosinophilic infiltration in the interfollicular area, accompanied by postcapillary venule proliferation with intermingled fibrotic changes. (× 100); C Magnification of the marked region with the rectangle in (B). Eosinophilic microabscesses (× 400)
The different characteristics of Orbital Lymphoma, EGPA and IgG4-RD with Kimura's disease
| Diseases | Kimura's disease | Orbital Lymphoma | EGPA | IgG4-RD |
|---|---|---|---|---|
| Clinical features | An immune-mediated inflammatory disorder; lymphadenopathy; subcutaneous nodules; painless; swelling in the head and neck is common | A malignant tumor arising as clonal expansions of B-lymphocytes, T-lymphocytes, or NK-cells; Lymphadenopathy; B symptoms (fever, night sweats, or weight loss, etc.) | An ANCA associated vasculitis; eosinophil-rich granulomatous; asthma; recurrent pneumonia; paranasal sinus infections; skin lesions (most commonly purpura); Mono- or poly-neuropathy | A fibroinflammatory condition; diffuse/localized swelling in single or multiple organs; non-specific, and overlap with various inflammatory and neoplastic conditions |
| Laboratory analysis | Peripheral blood eosinophil and IgE levels ↑↑ | Depending on histopathological subtype and the clinical stage; anemia, WBC↑are common | Peripheral blood eosinophilia > 10% total WBC; CRP level is median 2.5 ~ 6.6 mg/dl; 30 ~ 47% of patients ANCA ( +); serum IgE and IgG4 level↑ | Serum IgG4 > 135 mg/dl |
| Histopathological features | Hyperplasia of lymphoid follicular; enlargement of germinal center; infiltration or accumulation of eosinophils, even to form “eosinophilic abscess”; hyperplasia of postcapillary and venular with intermingled fibrotic changes | Effacement of lymph node architecture; rich inflammatory background, eosinophils and EBERs may be positive; immunohistochemical features to differentiate between B- and T-cell | Necrotizing small vasculitis accompanied by eosinophil infiltrates; perivascular and extravascular granulomas; palisading granuloma; fibrinoid necrosis in the wall of the vessels; rupture of internal elastic lamina | IgG4 + plasma cell infiltration; IgG4 + /IgG + of > 0.40, or a total of > 50 IgG4 + plasma cells/ high power field; storiform fibrosis; obliterative phlebitis; increased numbers of eosinophils, without eosinophilic granulomas |
| Available treatments | Glucocorticoids; immunosuppressants; surgery; local low-dose radiotherapy; anti-IgE monoclonal antibody(omalizumab) | Radiotherapy; chemotherapy; Glucocorticoids; surgery; Monoclonal antibodies (rituximab); Stem cell transplant | Glucocorticoids; immunosuppressants; monoclonal antibody: against interleukin-5 (mepolizumab); anti-CD20 (rituximab); Anti-IgE (omalizumab) | Glucocorticoids; immunosuppressants; anti-CD20 monoclonal antibody (rituximab) |
| References | [ | [ | [ | [ |
EGPA eosinophilic granulomatosis with polyangiitis, IgG4-RD IgG4-related disease, ANCA antineutrophil cytoplasmic antibody, WBC white blood cells, CRP c-reactive protein, EBERs EBV-encoded RNAs